全文获取类型
收费全文 | 2366篇 |
免费 | 102篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 113篇 |
妇产科学 | 32篇 |
基础医学 | 233篇 |
口腔科学 | 68篇 |
临床医学 | 186篇 |
内科学 | 522篇 |
皮肤病学 | 45篇 |
神经病学 | 111篇 |
特种医学 | 194篇 |
外科学 | 287篇 |
综合类 | 91篇 |
预防医学 | 95篇 |
眼科学 | 71篇 |
药学 | 250篇 |
中国医学 | 23篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 7篇 |
2022年 | 26篇 |
2021年 | 42篇 |
2020年 | 34篇 |
2019年 | 46篇 |
2018年 | 48篇 |
2017年 | 27篇 |
2016年 | 47篇 |
2015年 | 51篇 |
2014年 | 109篇 |
2013年 | 101篇 |
2012年 | 173篇 |
2011年 | 163篇 |
2010年 | 131篇 |
2009年 | 111篇 |
2008年 | 136篇 |
2007年 | 146篇 |
2006年 | 115篇 |
2005年 | 123篇 |
2004年 | 109篇 |
2003年 | 94篇 |
2002年 | 78篇 |
2001年 | 15篇 |
2000年 | 16篇 |
1999年 | 17篇 |
1998年 | 46篇 |
1997年 | 47篇 |
1996年 | 56篇 |
1995年 | 41篇 |
1994年 | 25篇 |
1993年 | 48篇 |
1992年 | 8篇 |
1991年 | 7篇 |
1990年 | 12篇 |
1989年 | 13篇 |
1988年 | 13篇 |
1987年 | 27篇 |
1986年 | 29篇 |
1985年 | 14篇 |
1984年 | 18篇 |
1983年 | 9篇 |
1982年 | 22篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1975年 | 10篇 |
1964年 | 2篇 |
排序方式: 共有2478条查询结果,搜索用时 15 毫秒
1.
D Gröne† R Treudler† EM de Villiers‡ R Husak† CE Orfanos† ChC Zouboulis†§ 《Journal of the European Academy of Dermatology and Venereology》2006,20(2):202-205
Cidofovir is an acyclic nucleoside phosphonate with broad-spectrum activity against DNA viruses, including human papilloma virus (HPV). However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory. We report for the first time on the promotion of the healing of recalcitrant warts in a patient with myelodysplastic syndrome with intravenous cidofovir treatment. 相似文献
2.
Pankaj Hari Anand Srivastava Arun Kumar Gupta Rajendra N. Srivastava 《Pediatric nephrology (Berlin, Germany)》1997,11(4):497-498
Acute renal failure (ARF) developed in a 7-week-old infant due to bilateral candidal bezoars (fungal balls) causing obstruction
at the pelviureteric junction. The baby was born at term with an appropriate birthweight, and had been treated with broad-spectrum
antibiotics for respiratory distress and septicemia during the 1st week of life. Recovery from ARF followed renal decompression
with bilateral nephrostomy tube placement and parenteral administration of amphotericin B and 5-flucytosine.
Received August 21, 1996; received in revised form and accepted January 3, 1997 相似文献
3.
4.
5.
Rajendra Nigam MD Richard Schottenfeld MD Thomas R. Kosten MD 《Journal of substance abuse treatment》1992,9(4):305-309
The authors describe the successful use of an adjunctive group psychotherapy for substance-abusing patients with major psychiatric disorders (bipolar, schizophrenia, schizoaffective, psychotic depression, and atypical psychosis). The group utilizes a psychoeducational approach that focuses on substance abuse causes and consequences, principles of recovery, and relapse prevention strategies. Eight patients with prolonged histories of abuse of cocaine, alcohol, marijuana, or other drugs were enrolled in this weekly group treatment at a community mental health center drug treatment program, while continuing in treatment with their current case manager or primary therapist. Six of the eight patients achieved periods of stable abstinence, documented by self-report, urine toxicology screens, continued group attendance, and improved social functioning. Case examples are utilized to illustrate the group process. 相似文献
6.
Dr. Smita K. Nagle Rajendra S. Kelkar 《Indian journal of otolaryngology and head and neck surgery》2007,59(1):41-42
Spirometry can be used as an objective tool for measuring nasal patency. it is sensitive, easy to perform, comfortable to patient The only limitation being that it only can be done in institution. 相似文献
7.
Dengue is a mosquito-borne viral disease caused by four antigenically distinct serotypes of dengue viruses (DENVs). This disease, which is prevalent in over a hundred tropical and sub-tropical countries of the world, represents a significant global public health problem. A tetravalent dengue vaccine capable of protecting against all four DENV serotypes has been elusive so far. Current efforts are focused on producing a tetravalent vaccine by mixing four monovalent vaccine components. In this work, we have utilized a discrete carboxy-terminal region of the major DENV envelope (E) protein, known as domain III (EDIII), which mediates virus entry into target cells and contains multiple serotype-specific neutralizing epitopes, to create a chimeric tetravalent antigen. This antigen derived by in-frame fusion of the EDIII-encoding sequences of the four DENV serotypes was expressed using a replication-defective recombinant human adenovirus type 5 (rAdV5) vaccine vector. This rAdV5 vector induced cell-mediated immune responses and virus-neutralizing antibodies specific to each of the four DENVs in mice. Interestingly, anti-AdV5 antibodies did not suppress the induction of DENV-specific neutralizing antibodies. We observed that anti-AdV5 antibodies in the sera of immunized mice could promote uptake of a rAdV5-derived reporter vector into U937 cells, suggesting that pre-existing immunity to AdV5 may in fact facilitate the uptake of rAdV5 vectored vaccines into antigen presenting cells. This work presents an alternative approach to developing a single component tetravalent vaccine that bypasses the complexities inherent in the currently adopted four-in-one physical mixture approach. 相似文献
8.
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 总被引:1,自引:0,他引:1
Collins CE Benson MJ Burnham WR Rampton DS 《Alimentary pharmacology & therapeutics》1996,10(3):315-320
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2 has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. METHODS: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. RESULTS: Increased amounts of thromboxane B2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147- 325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61- 140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64- 206), 8). Incubation with picotamide at concentrations between 100 microM and 1 mM reduced thromboxane B2 release (IC50 890 microM). CONCLUSION: Since increased thromboxane A2 production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease. 相似文献
9.
10.
Anuraag Shrivastav Shailly Varma Anurag Saxena John DeCoteau Rajendra K Sharma 《Journal of translational medicine》2007,5(1):58-6